Category: Emerging Infectious Diseases
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
Nature – With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not […]
Oct 13, 2022
Please Just Get the Dang Updated COVID Booster Shot
GQ – It’s good for you, it’s good for your community, and it’s widely available right now. This time around a pair of new vaccines, the updated or “bivalent” boosters from Pfizer and Moderna, could curb another winter spike. They’re both FDA-approved, and they both are designed to protect against the latest omicron sub-variants. They’re available near […]
Oct 13, 2022
Foreign Policy – Authorities are scrambling to quell the country’s biggest outbreak in two decades. Ugandan authorities are scrambling to quell a deadly Ebola outbreak that is believed to have killed 39 people and infected at least 54 people, fueling concerns of a wider public health crisis since the virus strain currently circulating has no available vaccine. The latest outbreak—Uganda’s biggest in two […]
Oct 13, 2022
Munich, Germany clinics: The situation is getting worse
The Munich Eye – Hospitals are again groaning more under Corona: 576 hospital beds are currently occupied by Corona patients in Munich hospitals. 37 of these are intensive care beds and 15 are intensive monitoring care beds. The increase compared to the previous week is massive: 98 beds more in total. But those are just […]
Oct 13, 2022
Uptick in COVID-Related Blood Clots: Is It Real?
MedPageToday – Since the beginning of the year when Omicron took hold in the U.S., physicians across the country have reported seeing fewer instances of blood clotting linked to COVID-19. However, recent social media postings from members of the medical community in the U.K. — which has served as a harbinger for what’s to come in the U.S. throughout […]
Oct 13, 2022
Risk of Covid death almost zero for people who are boosted and treated
CNBC– Dr. Ashish Jha, head of the White House Covid task force, said the U.S. has made major strides in fighting Covid since the early days of the pandemic. “If you are up to date with your vaccines and if you get treated if you have a breakthrough infection, your risk of dying from Covid […]
Oct 13, 2022
Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults
JAMA – In this systematic review and meta-analysis of 38 studies comprising 2160 participants, exercise capacity was reduced by 4.9 mL/kg/min among individuals with symptoms consistent with LC compared with individuals without symptoms more than 3 months after SARS-CoV-2 infection. Findings among individuals with exertional intolerance suggest that deconditioning, dysfunctional breathing, chronotropic incompetence, and abnormal […]
Oct 13, 2022
Studies suggest role for exercise testing in long COVID, impact of initial symptoms
CIDRAP – Two studies published today reveal new findings on long COVID, with one showing a possible role for cardiopulmonary exercise testing (CPET) for the evaluation of persistent symptoms, and the other finding a link between symptomatic infection and poor quality of life and reduced ability to complete daily activities. Continue reading
Oct 13, 2022
Around 12+ key companies are developing the Marburg Virus Disease Therapies | DelveInsight
Market screener – DelveInsight’s “Marburg Virus Disease Pipeline Insight” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Marburg Virus Disease pipeline landscapes. It comprises Marburg Virus Disease pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Marburg Virus Disease therapeutics assessment by product type, stage, route […]
Oct 12, 2022
Monkeypox treatment trial begins in the Democratic Republic of the Congo
NIH – A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. The National Institute of Allergy and […]
Oct 12, 2022